Join this webinar to learn about:
There have been a number of developments over the years in the biocides industry from regulatory clampdowns through to consolidations and divestments. This year we witnessed a record investment with the acquisition of Lonza Specialty Ingredients for US$4.7 billion a 13x EBITDA multiplier.
Note: Due to technical issues resulting from an overwhelming number of people working from home worldwide, our digital platform is having difficulties hosting events. To avoid unnecessary stress to attendees and with hopes that the platform will resolve their technical problems, we are postponing the live webinar to March 25, 2020.
Webinar Introduction: There have been a number of developments over the years in the biocide industry from regulatory clampdowns through to consolidations and divestments. This brief seminar aims to provide a high-level overview of Lonza’s specialty ingredients business in the context of the biocides and personal care markets.
This webinar is based on Kline’s just-published report covering Industrial Surfactants: Global Market Analysis and Opportunities. It will help you gain a general understanding of industrial applications driven by complex, application-related drivers, whose identification is key for building a successful, targeted business strategy.
The global pharmaceutical industry is facing a surge biologics. In recent years, biologic drugs have enjoyed a better approval rating than traditional drugs, as biologic drugs have been found to treat major chronic and complex diseases with higher safety and efficacy. The global production of biologics is expected to grow at a rate of around 10% annually.Continue reading
Southeast Asia is the fastest growing pharmaceutical market in the world, witnessing strong double-digit growth since 2011, with growth of excipients consumption in the region also strong and estimated to increase at a compound annual growth rate of 13.4% through 2020, finds recently published Specialty Excipients for Oral Solid-Dosage-Form Pharmaceuticals: Emerging Markets Analysis and Opportunities by global market research and management consulting firm Kline. Another excipients market analyzed in the report with solid pockets of opportunity is the Middle East and Africa region, forecast to progress at nearly 8% through 2020.Continue reading
The global economy is experiencing severe turmoil for a host of reasons; including the massive drop in the price of oil, the slowdown in growth in China, the concerns about lending and real estate bubbles in China, the economic and financial struggles in Europe, emerging economy travails, and geopolitical challenges in the Middle East.Continue reading
Kline, a respected provider of world-class consulting services and high-quality market intelligence, today announced recent additions to the company’s executive team. Kline is proud to announce the appointments of Annie Jarquin as Director in the Energy Practice and Hardeep Parmar as Director in the Chemicals Practice of Kline’s Management Consulting business. Their respective experience will help to strengthen Kline’s abilities, reputation, and, most importantly, add value for our clients within the energy/lubricants and chemicals industries.Continue reading
Europe and CIS together account for a total 23% of the global synthetic latex polymers market in 2014. While consumption of synthetic latex polymers in CIS remains low, the region offers high growth potential. Import substitution programs implemented by the Russian government along with the strategic development of chemical industry plans across the majority of CIS countries will drive the synthetic latex market in the region, estimated to increase at 2.6% through 2019,finds the recently published analysis of the CIS and European regions from Kline’s Synthetic Latex Polymers: Global Business Analysis and Opportunities report. However, the political and economical instability in the region could decelerate this growth.